Company profile: enGene
1.1 - Company Overview
Company description
- Provider of biotechnological treatments for mucosal diseases by inducing therapeutic proteins.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to enGene
GeneThera
HQ: United States
Website
- Description: Provider of biotechnology applying molecular technologies to improve food safety and eradicate zoonotic diseases, including Johne's Disease, Mad Cow Disease, Chronic Wasting Disease, and E.coli, affecting terrestrial, avian, and aquatic animals.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full GeneThera company profile →
Smart Therapeutics
HQ: United States
Website
- Description: Provider of biopharmaceutical drug discovery and development focused on orally administered drugs.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Smart Therapeutics company profile →
Verge Genomics
HQ: United States
Website
- Description: Provider of an AI-powered, all-in-human drug discovery platform (CONVERGE®) integrating proprietary human genomics and computational tools to predict new drugs; developer of VRG50635, a PIKfyve inhibitor for ALS; and collaborator with industry and academic partners, including Alexion/AstraZeneca Rare Disease, Eli Lilly, and SITraN, to co-develop clinical-stage and novel therapies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Verge Genomics company profile →
Constellation Pharmaceuticals
HQ: United States
Website
- Description: Provider of novel therapeutics in the emerging field of epigenetics, focusing on selective regulators of epigenetic function critical to controlling gene expression; the first biopharmaceutical company dedicated to this area.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Constellation Pharmaceuticals company profile →
Fluent Biosciences
HQ: United States
Website
- Description: Provider of single-cell molecular analysis solutions without complex microfluidic instrumentation via its PIPseq Pre-Templated Instant Partitions platform for instantaneous self-assembly. Offers 3’ Single Cell RNA Kits (T2, T20, T100) for profiling up to 100,000 cells, a nuclei isolation kit, unique dual index kits for Illumina NGS instruments, and supplemental enrichment/amplification kits.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Fluent Biosciences company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for enGene
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to enGene
2.2 - Growth funds investing in similar companies to enGene
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for enGene
4.2 - Public trading comparable groups for enGene
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →